Brexit - UK Medtech Takes Decisive View In ABHI Survey
This article was originally published in SRA
Executive Summary
As promised in mid-April, and just a month away from the UK's yes/no vote on continued membership of the EU, the UK medtech industry association ABHI has completed and released a survey of its members' views on this theme - its second within the past year1.
You may also be interested in...
UK Medtech One Year Post-Brexit Vote: Still In The Land of Uncertainty
The UK's Brexit and a failed Conservative Party election strategy last month weigh heavily on the minds of local medtech businesses, looking ahead nervously at the type of trade deal the UK might finally strike with the EU. They could be waiting a while, because the When and What are still not yet apparent – never mind that the Why still rankles with many UK medtechs. That much is clear from a brand new survey of companies, which also reveals the primacy of NHS access.
UK Medtech Rises Up To Meet The Challenges Of Brexit
How the UK medtech industry can forge successful international relationships, increase health-care delivery efficiency and improve patient outcomes following Brexit are the challenges taken up by the Association of British Healthcare Industries in a new report.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.